Insider Shareholders with Direct Ownership of Avalo Therapeutics, Inc. (AVTX)
This section provides a comprehensive overview of the insiders with direct ownership of Avalo Therapeutics, Inc. (AVTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Avalo Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Armistice Capital, Llc
> 10% Shareholder |
26,969,671 | 3,455,129 | 39,100,000 $380 Million | 129 |
May 18, 2021
Added 0.06%
|
|
James Archie Harrell Jr
Chief Commercial Officer |
8,757 | 0 | 36,766 $357,733 | 3 |
Dec 10, 2021
Added 2.89%
|
|
H Jeffrey Wilkins
Chief Medical Officer |
7,283 | 0 | 33,373 $324,719 | 2 |
Dec 10, 2021
Added 16.03%
|
|
Garry Arthur Neil
CEO and Chairman of the Board |
17,641 | 0 | 13,220 $128,630 | 5 |
Jun 09, 2023
Added 23.23%
|
| 2,883 | 0 | 3,883 $37,781 | 2 |
Dec 10, 2021
Added 36.49%
|
|
|
Christopher Ryan Sullivan
Chief Financial Officer |
6,561 | 0 | 1,262 $12,279 | 3 |
Jun 09, 2023
Added 28.82%
|
|
Caissa Capital Management Ltd.
> 10% Shareholder |
0 | 182,300 | 0 $0 | 1 |
Jun 26, 2023
Reduced 100.0%
|